Geode Capital Management LLC Buys 243,802 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Geode Capital Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,756,727 shares of the medical equipment provider's stock after purchasing an additional 243,802 shares during the quarter. Geode Capital Management LLC owned 2.18% of Intuitive Surgical worth $4,039,200,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the period. State Street Corp raised its holdings in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. Fisher Asset Management LLC boosted its position in Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after buying an additional 86,488 shares during the period. Norges Bank bought a new stake in Intuitive Surgical in the 4th quarter worth $2,401,493,000. Finally, Wellington Management Group LLP increased its position in shares of Intuitive Surgical by 1.7% in the third quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider's stock valued at $1,530,318,000 after acquiring an additional 53,383 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Activity

In related news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 in the last ninety days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Down 8.7 %

ISRG stock traded down $43.03 on Friday, hitting $451.58. The company had a trading volume of 4,106,917 shares, compared to its average volume of 1,543,183. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock has a market cap of $160.84 billion, a price-to-earnings ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. The stock's 50-day simple moving average is $545.18 and its 200 day simple moving average is $532.64.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. Truist Financial decreased their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a report on Monday, March 17th. Finally, Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.